Autopsy report · NCT04244006

A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome

“no more patients corresponding to the criteriae”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 2 years 4 months before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

University Hospital, Toulouse

Sponsor type

University, hospital or other

Conditions

Netherton Syndrome

Interventions

Dupilumab Prefilled Syringe; Placebo Prefilled Syringe

Participants

10

Sites

2

Countries

France

Trials that died the same way

• Efficacy of Acetaminophen in Posterior Fossa Surgery
  “not enough patients meeting criteria” (79% match in meaning)
• Endothelial Protection in Convalescent COVID-19 Patients
  “Lack of the eligible patients” (73% match in meaning)
• Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
  “Not enough eligible patients available” (72% match in meaning)
• Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)
  “Lack of eligible patients” (72% match in meaning)
• Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain
  “Due to lack of patients number” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.